Santlal, Kiran and Gibbons, Zorina and McCarron, Peter and Keenan, Eamon (2017) Gamma Hydroxybutyrate & Gamma Butrolactone (GHB/GBL): a case series of inpatient & outpatient detoxification. In: Club Health Dublin, 24-26 June 2017, Dublin.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Gamma Hydroxybutyrate & Gamma Butrolactone (GHB/GBL): a case series of inpatient & outpatient detoxification)
3MB |
GHB is a natural endogenous neurotransmitter. It can also be ingested orally and crosses the blood-brain barrier. It is structurally similar to gamma-aminobutyric acid (GABA) and acts on GABA & GHB receptors in brain with effects on the dopaminergic system. It is rapidly eliminated and not detectable after: 4 hours in the blood 12 hours in the urine.
This poster includes: Symptoms of GHB overdose and withdrawal, Management of GHB overdose and withdrawal, Treatment episodes & outcomes in the GHB clinic.
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Gabapentinoids GABA (Pregabalin / Gabapentin)
B Substances > New (novel) psychoactive substances > GHB (Gamma hydroxybutyric acid)
HJ Treatment method > Treatment outcome
J Health care, prevention, harm reduction and rehabilitation > Health related issues > Health information and education > Communicable / infectious disease control > Safe sex
L Social psychology and related concepts > Social context
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page